(94 days)
No
The summary describes a physical contact lens and its materials, with no mention of software, algorithms, or data processing that would indicate AI/ML.
Yes
The device is indicated for conditions like adult and pediatric aphakia and irregular astigmatism created by keratoconus, trauma, or post-keratoplasty, which are therapeutic applications beyond simple vision correction. Its use after corneal refractive surgery also suggests a therapeutic role in managing post-surgical conditions.
No
The device is a soft contact lens intended for the correction of refractive ametropia and specialized uses (like aphakia or irregular astigmatism), which falls under treatment or correction, not diagnosis.
No
The device description clearly describes a physical contact lens made from specific materials, which is a hardware device, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the correction of refractive ametropia and specialized uses like aphakia and irregular astigmatism. This is a therapeutic and corrective function, not a diagnostic one.
- Device Description: The description focuses on the physical properties and function of the contact lens in correcting vision by conforming to the eye. It does not describe any components or processes for analyzing biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing samples from the human body (blood, urine, tissue, etc.) or providing information about a physiological state, disease, or condition based on such analysis.
The device is a medical device, specifically a contact lens, used for vision correction.
N/A
Intended Use / Indications for Use
The Flexlens (hioxifilcon A), (acofilcon B), (acofilcon B) Soft Contact Lens for Daily Wear (lathe-cut) are indicated for daily wear use for the correction of refractive ametropia and specialized use such as atypical ametropia. Examples include, but are not limited to: adult and pediatric aphakia, and irregular astigmatism created by keratoconus, trauma, or post keratoplasty.
The Flexiens (hioxifilcon A), (acofilcon B), (acofilcon B) Harrison Post Refractive Surgery Soft Contact Lens for Daily Wear (lathe-cut) are indicated for daily wear use for the correction of refractive ametropia and specialized use such as atypical ametropia following corneal refractive surgery.
The lens may be disinfected with a chemical (not heat) disinfection system.
Product codes (comma separated list FDA assigned to the subject device)
LPL
Device Description
The Flexlens and Harrison Post Refractive Surgery (hioxifilcon B), (acofilcon A), (acofilcon B) Soft Contact Lens for Daily Wear (lathe-cut) is fabricated from one of the above materials which in the dry (unhydrated) state may be machined and polished. The hydrophilic nature of this material allows the lens to become soft and pliable when immersed in an aqueous solution.
In the hydrated state, the lens conforms to the curvature of the eve covering the cornea and extending slightly beyond the limbus forming a colorless, transparent optical surface. The hydrophilic properties of the lens require that it be maintained in a fully hydrated state in a solution compatible with the eye. If the lens dries out, it will become hard appear somewhat warped however, it will return to its proper configuration when completely rehydrated in the proper storage solution.
The non-ionic lens material, hioxifilcon A, is a copolymer of 2-hydroxyethyl methacrylate (2-HEMA) and 2,3-Dihydrosypropyl Methacrylate (Glycerol Methacrylate, GMA). It consists of 41% hioxifileon A and 59% water by weight when immersed in normal saline solution buffered with sodium bicarbonate. The lenses are available in clear and with a blue visibility-handling tint, phthalocyanato (2) - (copper),
The non-ionic lens material, hioxifilcon B, is a copolymer of 2-hydroxyethyl methacrylate (2-HEMA) and 2,3-Dihydrosypropyl Methacrylate (Glycerol Methacrylate, GMA). It consists of 52% hioxifileon B and 48% water by weight when immersed in normal saline solution buffered with sodium bicarbonate. The lenses are available in clear and with a blue visibility-handling tint, phthalocyanato (2) - (copper).
The non-ionic lens material, acofilcon A, is a terpolymer based on high purity Glycerol Methacrylate2,3-Dihydroxypropyl Methacrylate (GMA), with N-vinyl-2 pyrrolidone (NVP), methyl methacrylate (MMA), and 2-hydroxyethy) methacrylate (2-HEMA) and crossed-linked with Diallyl Maleate (DAM). It consists of 42% acofilcon A and 58% water by weight when immersed in normal saline solution buffered with sodium bicarbonate. The lenses are available in clear and with a blue visibility-handling tint, Color additive 'Reactive Blue 4'..
The non-ionic lens material, acofilcon B, is a terpolymer based on high purity Glycerol Methacrylate2,3-Dihydroxypropyl Methacrylate (GMA), with N-vinyl-2 pyrrolidone (NVP), methyl methacrylate (MMA), and 2-hydroxyethyl methacrylate (2-HEMA) and crossed-linked with Diallyl Maleate (DAM). It consists of 51% acofilcon B and 49% water by weight when immersed in normal saline solution buffered with sodium bicarbonate. The lenses are available in clear and with a blue visibility-handling tint, Color additive 'Reactive Blue 4'.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Cornea, eye
Indicated Patient Age Range
Adult and pediatric
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Pre-Clinical Performance Data:
hioxifilcon A: Pre-clinical performance data addressing the cytotoxicity test, systemic injection test, and ocular eye irritation test for can be referenced for the hioxifilcon A in Benz Research and Development's 510(k) K983773.
hioxifilcon B: Pre-clinical performance data addressing the cytotoxicity test, systemic injection test, and ocular eve irritation test for can be referenced for the hioxifilcon B in Benz Research and Development's 510(k) K964528.
acofilcon A: Pre-clinical performance data addressing the cytotoxicity test, systemic injection test, and ocular eye irritation test for can be referenced for the acofilcon A in Contamac Ltd.'s 510(k) K023349.
acofilcon B: Pre-clinical performance data addressing the cytotoxicity test, systemic injection test, and ocular eye irritation test for can be referenced for the acofilcon B in Contamac Ltd.'s 510(k) K024045.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
K983773, K964528, K023349, K024045
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 886.5925 Soft (hydrophilic) contact lens.
(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.
0
510 (k) SUMMARY OF SAFETY AND EFFECTIVENESS
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
| The assigned 510(k) number is: | K030593 |
|---|---|
| Applicant information: | |
| Date Prepared: | February 19, 2002 |
| Name: | |
| Address | X-cel Contacts / Flexlens Products |
| 2775 Premier Pkwy., Suite 600 | |
| Duluth, GA 30097 | |
| Contact Person: | |
| Phone number: | Robert Chambers |
| (770) 622-9235 | |
| USA Consultant: | Martin Dalsing |
| Medvice Consulting, Inc. | |
| 623 Glacier Drive | |
| Grand Junction, CO 81503 | |
| Phone number | (970) 243-5490 |
| Fax (970) 243-5501 | |
| Email: mdalsing@fdapproval.com | |
| Device Information: |
| Device Classification: | Class II |
|---|---|
| Classification Number: | LPL |
| Classification Name: | Lenses, Soft Contact, Daily Wear |
| Trade Name: | Flexlens and Harrison Post Refractive Surgery (hioxifilcon A), (hioxifilcon B), (acofilcon A), (acofilcon B) Soft Contact Lens for Daily Wear (lathe-cut) |
1
Purpose of 510(k) submission:
ADDITION of MATERIALS ~
The purpose of this 510(k) submission is for X-cel Contacts / Flexlens Products to receive clearance to manufacture their Flexlens Soft Contact Lens for Daily Wear and Harrison Post Refractive Surgery Soft Contact Lens for Daily Wear out of four (4) additional FDA cleared hydrophilic contact lens materials. The additional materials are (hioxifilcon A), (hioxifilcon B), (acofilcon A) and (acofilcon B).
X-cel Contacts / Flexlens Products, proposes to manufacture the Flexlens and Harrison Post Refractive Surgery (hioxifilcon B), (hioxifilcon B), (acofilcon B) Soft Contact Lens for Daily Wear (lathe-cut). Data supporting substantial equivalency to the predicate devices, performance, and safety and efficacy of the Flexlens and Harrison Post Refractive Surgery (hioxifilcon A), (hioxifilcon B), (acofilcon A), (acofilcon B) Soft Contact Lens for Daily Wear (lathe-cut) is contained in this submission.
Equivalent Device:
The Flexlens and Harrison Post Refractive Surgery (hioxifilcon B), (acofilcon A), (acofilcon B) Soft Contact Lens for Daily Wear (lathe-cut) is substantially equivalent to the following predicate devices.
- Flexlens (methafilcon A) Harrison Post Refractive Surgery Soft Contact Lens for Daily Wear . manufactured by X-cel / Flexlens Products (K950294)
- Flexlens (hefilcon A) Harrison Post Refractive Surgery Soft Contact Lens for Daily Wear ● manufactured by X-cel / Flexlens Products (K961943)
- Flexlens 55 Soft (Hydrophilic) manufactured by X-cel Contacts / Flexlens Products (K950295) .
Device Description:
The Flexlens and Harrison Post Refractive Surgery (hioxifilcon B), (acofilcon A), (acofilcon B) Soft Contact Lens for Daily Wear (lathe-cut) is fabricated from one of the above materials which in the dry (unhydrated) state may be machined and polished. The hydrophilic nature of this material allows the lens to become soft and pliable when immersed in an aqueous solution.
In the hydrated state, the lens conforms to the curvature of the eve covering the cornea and extending slightly beyond the limbus forming a colorless, transparent optical surface. The hydrophilic properties of the lens require that it be maintained in a fully hydrated state in a solution compatible with the eye. If the lens dries out, it will become hard appear somewhat warped however, it will return to its proper configuration when completely rehydrated in the proper storage solution.
2
The non-ionic lens material, hioxifilcon A, is a copolymer of 2-hydroxyethyl methacrylate (2-HEMA) and 2,3-Dihydrosypropyl Methacrylate (Glycerol Methacrylate, GMA). It consists of 41% hioxifileon A and 59% water by weight when immersed in normal saline solution buffered with sodium bicarbonate. The lenses are available in clear and with a blue visibility-handling tint, phthalocyanato (2) - (copper),
The physical properties of the hioxifilcon A lens are:
| Refractive Index | 1.404 (hydrated) |
|---|---|
| Light Transmission (clear) | greater than 95% T |
| Light Transmission (tinted) | greater than 95% T |
| Water Content | 59% |
| Specific Gravity | 1.18 (hydrated) |
| Oxygen Permeability | 18 X 10 -11 (cm 2 /sec) (ml O₂/ml x mm Hg @ 35°C), (revised Fatt method). |
The non-ionic lens material, hioxifilcon B, is a copolymer of 2-hydroxyethyl methacrylate (2-HEMA) and 2,3-Dihydrosypropyl Methacrylate (Glycerol Methacrylate, GMA). It consists of 52% hioxifileon B and 48% water by weight when immersed in normal saline solution buffered with sodium bicarbonate. The lenses are available in clear and with a blue visibility-handling tint, phthalocyanato (2) - (copper).
The physical properties of the hioxifilcon B lens are:
| Refractive Index | 1.404 (hydrated) |
|---|---|
| Light Transmission (clear) | greater than 95% T |
| Light Transmission (tinted) | greater than 95% T |
| Water Content | 48 % |
| Specific Gravity | 1.136 (hydrated) |
| Oxygen Permeability | $15 X 10^{-11}$ (cm2/sec) (ml O₂/ml x mm Hg @ 35°C), (revised Fatt |
| method) |
The non-ionic lens material, acofilcon A, is a terpolymer based on high purity Glycerol Methacrylate2,3-Dihydroxypropyl Methacrylate (GMA), with N-vinyl-2 pyrrolidone (NVP), methyl methacrylate (MMA), and 2-hydroxyethy) methacrylate (2-HEMA) and crossed-linked with Diallyl Maleate (DAM). It consists of 42% acofilcon A and 58% water by weight when immersed in normal saline solution buffered with sodium bicarbonate. The lenses are available in clear and with a blue visibility-handling tint, Color additive 'Reactive Blue 4'..
The physical properties of the acofilcon A lens are:
| Refractive Index | 1.40 (hydrated) |
|---|---|
| Light Transmission (clear) | greater than 93% T |
| Light Transmission (tinted) | greater than 93% T |
| Water Content | 58 % |
| Specific Gravity | 1.103 (hydrated) |
| Oxygen Permeability | 25.50 X 10-11 (cm2/sec) (ml O₂/ml x mm Hg @ 35°C), (revised Fatt method). |
3
The non-ionic lens material, acofilcon B, is a terpolymer based on high purity Glycerol Methacrylate2,3-Dihydroxypropyl Methacrylate (GMA), with N-vinyl-2 pyrrolidone (NVP), methyl methacrylate (MMA), and 2-hydroxyethyl methacrylate (2-HEMA) and crossed-linked with Diallyl Maleate (DAM). It consists of 51% acofilcon B and 49% water by weight when immersed in normal saline solution buffered with sodium bicarbonate. The lenses are available in clear and with a blue visibility-handling tint, Color additive 'Reactive Blue 4'.
The physical properties of the acofilcon B lens are:
| Refractive Index | 1.42 (hydrated) |
|---|---|
| Light Transmission (clear) | greater than 96% T |
| Light Transmission (tinted) | greater than 96% T |
| Water Content | 49 % |
| Specific Gravity | 1.142 (hydrated) |
| Oxygen Permeability | 15.8 X 10-11 (cm2/sec) (ml O 2/ml x mm Hg @ 35°C), (revised Fatt |
| method). |
Pre-Clinical Performance Data:
(Reference Permission to Reference letters appendix D)
hioxifilcon A
Pre-clinical performance data addressing the cytotoxicity test, systemic injection test, and ocular eye irritation test for can be referenced for the hioxifilcon A in Benz Research and Development's 510(k) K983773.
hioxifilcon B
Pre-clinical performance data addressing the cytotoxicity test, systemic injection test, and ocular eve irritation test for can be referenced for the hioxifilcon B in Benz Research and Development's 510(k) K964528.
acofilcon A
Pre-clinical performance data addressing the cytotoxicity test, systemic injection test, and ocular eye irritation test for can be referenced for the acofilcon A in Contamac Ltd.'s 510(k) K023349.
acofilcon B
Pre-clinical performance data addressing the cytotoxicity test, systemic injection test, and ocular eye irritation test for can be referenced for the acofilcon B in Contamac Ltd.'s 510(k) K024045.
4
Substantial Equivalence:
The device will be manufactured according to specified process controls and a quality assurance program already in place at X-cel Contacts / Flexlens Products. The device will undergo manufacturing, packaging and sterilization procedures similar to devices currently marketed and distributed by X-cel Contacts / Flexlens Products.
The device is similar with respect to indications for use, materials, physical construction and safety & effectiveness to the predicate device, this meets the requirements per section 510(k) of the act regarding substantial equivalence and does not raise different questions of safety and effectiveness than the predicate devices identified above.
The following table illustrates that the production method, lens function and indications for use of the Flexlens and Harrison Post Refractive Surgery (hioxifilcon A), (hioxifilcon B), (acofilcon A), (acofilcon B) Soft Contact Lens for Daily Wear (lathe-cut) substantially equivalent to the predicate devices.
5
Substantial Equivalence Table
| New Device | Predicate Device | ||
|---|---|---|---|
| CHARACTERISTICS | Flexlens and Harrison Post Refractive | ||
| Surgery (hioxifilcon A), (hioxifilcon | |||
| B), (acofilcon A), (acofilcon B) Soft | |||
| Contact Lens for Daily Wear (lathe-cut) | Flexlens and Harrison Post Refractive | ||
| Surgery (methafilcon A) (hefilcon A) | |||
| Soft Contact Lens for Daily Wear | |||
| (lathe-cut) K962000, K961943 & | |||
| N17976 | |||
| 1.) | INDICATION | Daily wear, Soft Contact Lens | |
| 2.) | INTENDED USE | The Flexlens (hioxifilcon A), (hioxifilcon B), | |
| (acofilcon A), (acofilcon B) Soft Contact Lens for | |||
| Daily Wear (lathe-cut) are indicated for daily wear | |||
| use for the correction of refractive ametropia and | |||
| specialized use such as atypical ametropia. Examples | |||
| include, but are not limited to: adult and pediatric | |||
| aphakia, and irregular astigmatism created by | |||
| keratoconus, trauma, or post keratoplasty. |
The Flexlens (hioxifilcon A), (hioxifilcon B),
(acofilcon A), (acofilcon B) Harrison Post Refractive
Surgery Soft Contact Lens for Daily Wear (lathe-cut)
are indicated for daily wear use for the correction of
refractive ametropia and specialized use such as
atypical ametropia following corneal refractive
surgery. |
| 3.) | | PRODUCTION
METHOD | Lathe-Cut |
| 4.) | | HYDROPHILLIC
MATERIAL/
USAN | (hioxifilcon A)
(hioxifilcon B)
(acofilcon A)
(acofilcon B) |
| a. | Water Content | (hioxifilcon A) - 59%
(hioxifilcon B) - 48%
(acofilcon A) - 58%
(acofilcon B) - 49% | (methafilcon A) - 55%
(hefilcon A) - 45% |
| b. | Specific Gravity | (hioxifilcon A) - 1.18 (hydrated)
(hioxifilcon B) - 1.136 (hydrated)
(acofilcon A) - 1.103 (hydrated)
(acofilcon B) - 1.142 (hydrated) | (methafilcon A) - 1.090
(hefilcon A) - 0.979 |
| C. | Oxygen Permeability
- Revised FATT method | (hioxifilcon A) - 18.0
(hioxifilcon B) - 15.0
(acofilcon A) - 25.5
(acofilcon B) - 15.8 | (methafilcon A) - 18.8
(hefilcon A) - 16.0 |
| d. | Light Transmittance | (hioxifilcon A) - >95%
(hioxifilcon B) - >95%
(acofilcon A) - >93%
(acofilcon B) - >96% | (methafilcon A) - >95%
(hefilcon A) - >95% |
| e. | Refractive Index | (hioxifilcon A) - 1.40 (hydrated)
(hioxifilcon B) - 1.40 (hydrated)
(acofilcon A) - 1.40 (hydrated)
(acofilcon B) - 1.42 (hydrated) | (methafilcon A) - 1.40 (hydrated)
(hefilcon A) - 1.43 (hydrated) |
6
Image /page/6/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it, often used as a symbol of medicine. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the caduceus.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAY 3 0 2003
X-cel Contacts/FlexIens Products c/o Mr. Martin Dalsing Medvice Consulting, Inc. 623 Glacier Drive Grand Junction, CO 81503
Re: K030593
Trade/Device Name: Flexlens and Harrison Post Refractive Surgery (hioxifilcon A), (hioxifilcon B), (acofilcon A), (acofilcon B) Soft Contact Lens for Daily Wear (lathe-cut)
Regulation Number: 21 CFR 886.5925 Regulation Name: Soft (hydrophilic) contact lens Regulatory Class: Class II Product Code: LPL Dated: May 05, 2002 Received: May 08, 2003
Dear Mr. Dalsing:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
7
Page 2 – Mr. Martin Dalsing
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4613. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
A. haleri Rosenthal
A. Ralph Rosenthal, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
8
INDICATIONS FOR USE STATEMENT
Device Name: Flexlens and Harrison Post Refractive Surgery (hioxifilcon A), (hioxifilcon B), (acofilcon A), (acofilcon B) Soft Contact Lens for Daily Wear (lathe-cut)
INDICATIONS FOR USE:
The Flexlens (hioxifilcon A), (acofilcon B), (acofilcon B) Soft Contact Lens for Daily Wear (lathe-cut) are indicated for daily wear use for the correction of refractive ametropia and specialized use such as atypical ametropia. Examples include, but are not limited to: adult and pediatric aphakia, and irregular astigmatism created by keratoconus, trauma, or post keratoplasty.
The Flexiens (hioxifilcon A), (acofilcon B), (acofilcon B) Harrison Post Refractive Surgery Soft Contact Lens for Daily Wear (lathe-cut) are indicated for daily wear use for the correction of refractive ametropia and specialized use such as atypical ametropia following corneal refractive surgery.
The lens may be disinfected with a chemical (not heat) disinfection system.
(PLEASE DO OT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) | |
| Division of Ophthalmic Ear, Nose and Throat Devises | |
| 510(k) Number | K030593 |
| Prescription Use (Per 21 CFR 801.109) | or | Over-The-Counter Use ______ |
|---|---|---|
| ------------------------------------------------------------------------------------ | ---- | ----------------------------- |
(Optional Format 1-2-96)